These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 34046736

  • 1. Hemoconcentration and predictors in Shiga toxin-producing E. coli-hemolytic uremic syndrome (STEC-HUS).
    Loos S, Oh J, van de Loo L, Kemper MJ, Blohm M, Schild R.
    Pediatr Nephrol; 2021 Nov; 36(11):3777-3783. PubMed ID: 34046736
    [Abstract] [Full Text] [Related]

  • 2. Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli in children: incidence, risk factors, and clinical outcome.
    Ylinen E, Salmenlinna S, Halkilahti J, Jahnukainen T, Korhonen L, Virkkala T, Rimhanen-Finne R, Nuutinen M, Kataja J, Arikoski P, Linkosalo L, Bai X, Matussek A, Jalanko H, Saxén H.
    Pediatr Nephrol; 2020 Sep; 35(9):1749-1759. PubMed ID: 32323005
    [Abstract] [Full Text] [Related]

  • 3. Predicting Hemolytic Uremic Syndrome and Renal Replacement Therapy in Shiga Toxin-producing Escherichia coli-infected Children.
    McKee RS, Schnadower D, Tarr PI, Xie J, Finkelstein Y, Desai N, Lane RD, Bergmann KR, Kaplan RL, Hariharan S, Cruz AT, Cohen DM, Dixon A, Ramgopal S, Rominger A, Powell EC, Kilgar J, Michelson KA, Beer D, Bitzan M, Pruitt CM, Yen K, Meckler GD, Plint AC, Bradin S, Abramo TJ, Gouin S, Kam AJ, Schuh A, Balamuth F, Hunley TE, Kanegaye JT, Jones NE, Avva U, Porter R, Fein DM, Louie JP, Freedman SB, Pediatric Emergency Medicine Collaborative Research Committee and Pediatric Emergency Research Canada.
    Clin Infect Dis; 2020 Apr 10; 70(8):1643-1651. PubMed ID: 31125419
    [Abstract] [Full Text] [Related]

  • 4. Bloody Diarrhea and Shiga Toxin-Producing Escherichia coli Hemolytic Uremic Syndrome in Children: Data from the ItalKid-HUS Network.
    Ardissino G, Vignati C, Masia C, Capone V, Colombo R, Tel F, Daprai L, Testa S, Dodaro A, Paglialonga F, Luini M, Brigotti M, Picicco D, Baldioli C, Pagani F, Ceruti R, Tommasi P, Possenti I, Cresseri D, Consonni D, Montini G, Arghittu M, ItalKid-HUS Network.
    J Pediatr; 2021 Oct 10; 237():34-40.e1. PubMed ID: 34197890
    [Abstract] [Full Text] [Related]

  • 5. Unusual severe case of hemolytic uremic syndrome due to Shiga toxin 2d-producing E. coli O80:H2.
    Wijnsma KL, Schijvens AM, Rossen JWA, Kooistra-Smid AMDM, Schreuder MF, van de Kar NCAJ.
    Pediatr Nephrol; 2017 Jul 10; 32(7):1263-1268. PubMed ID: 28343354
    [Abstract] [Full Text] [Related]

  • 6. Volume expansion mitigates Shiga toxin-producing E. coli-hemolytic uremic syndrome in children.
    Böckenhauer J, Schild R, Kemper MJ, Henne T, Stein MV, Oh J, Loos S.
    Pediatr Nephrol; 2024 Jun 10; 39(6):1901-1907. PubMed ID: 38240870
    [Abstract] [Full Text] [Related]

  • 7. Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry.
    Kielstein JT, Beutel G, Fleig S, Steinhoff J, Meyer TN, Hafer C, Kuhlmann U, Bramstedt J, Panzer U, Vischedyk M, Busch V, Ries W, Mitzner S, Mees S, Stracke S, Nürnberger J, Gerke P, Wiesner M, Sucke B, Abu-Tair M, Kribben A, Klause N, Schindler R, Merkel F, Schnatter S, Dorresteijn EM, Samuelsson O, Brunkhorst R, Collaborators of the DGfN STEC-HUS registry.
    Nephrol Dial Transplant; 2012 Oct 10; 27(10):3807-15. PubMed ID: 23114903
    [Abstract] [Full Text] [Related]

  • 8. Serum neutrophil gelatinase-associated lipocalin (NGAL) in patients with Shiga toxin mediated haemolytic uraemic syndrome (STEC-HUS).
    Lukasz A, Beneke J, Menne J, Vetter F, Schmidt BM, Schiffer M, Haller H, Kümpers P, Kielstein JT.
    Thromb Haemost; 2014 Feb 10; 111(2):365-72. PubMed ID: 24172823
    [Abstract] [Full Text] [Related]

  • 9. Associations Between Hydration Status, Intravenous Fluid Administration, and Outcomes of Patients Infected With Shiga Toxin-Producing Escherichia coli: A Systematic Review and Meta-analysis.
    Grisaru S, Xie J, Samuel S, Hartling L, Tarr PI, Schnadower D, Freedman SB, Alberta Provincial Pediatric Enteric Infection Team.
    JAMA Pediatr; 2017 Jan 01; 171(1):68-76. PubMed ID: 27893870
    [Abstract] [Full Text] [Related]

  • 10. Infections in pediatric postdiarrheal hemolytic uremic syndrome: factors associated with identifying shiga toxin-producing Escherichia coli.
    Mody RK, Luna-Gierke RE, Jones TF, Comstock N, Hurd S, Scheftel J, Lathrop S, Smith G, Palmer A, Strockbine N, Talkington D, Mahon BE, Hoekstra RM, Griffin PM.
    Arch Pediatr Adolesc Med; 2012 Oct 01; 166(10):902-9. PubMed ID: 22869280
    [Abstract] [Full Text] [Related]

  • 11. Use of complement monoclonal antibody eculizumab in Shiga toxin producing Escherichia coli associated hemolytic uremic syndrome: A review of current evidence.
    Mahat U, Matar RB, Rotz SJ.
    Pediatr Blood Cancer; 2019 Nov 01; 66(11):e27913. PubMed ID: 31286658
    [Abstract] [Full Text] [Related]

  • 12. CFH gene mutation in a case of Shiga toxin-associated hemolytic uremic syndrome (STEC-HUS).
    Caillaud C, Zaloszyc A, Licht C, Pichault V, Frémeaux-Bacchi V, Fischbach M.
    Pediatr Nephrol; 2016 Jan 01; 31(1):157-61. PubMed ID: 26399238
    [Abstract] [Full Text] [Related]

  • 13. An epidemiologic surveillance of Shiga-like toxin-producing Escherichia coli infection in Argentinean children: risk factors and serum Shiga-like toxin 2 values.
    López EL, Contrini MM, Glatstein E, Ayala SG, Santoro R, Ezcurra G, Teplitz E, Matsumoto Y, Sato H, Sakai K, Katsuura Y, Hoshide S, Morita T, Harning R, Brookman S.
    Pediatr Infect Dis J; 2012 Jan 01; 31(1):20-4. PubMed ID: 21829137
    [Abstract] [Full Text] [Related]

  • 14. C3 levels and acute outcomes in Shiga toxin-related hemolytic uremic syndrome.
    Balestracci A, Meni Bataglia L, Toledo I, Beaudoin L, Alvarado C.
    Pediatr Nephrol; 2020 Feb 01; 35(2):331-339. PubMed ID: 31475299
    [Abstract] [Full Text] [Related]

  • 15. Comparative genomic analysis of a Shiga toxin-producing Escherichia coli (STEC) O145:H25 associated with a severe pediatric case of hemolytic uremic syndrome in Davidson County, Tennessee, US.
    Guerra JA, Zhang C, Bard JE, Yergeau D, Halasa N, Gómez-Duarte OG.
    BMC Genomics; 2020 Aug 17; 21(1):564. PubMed ID: 32807093
    [Abstract] [Full Text] [Related]

  • 16. Hemolytic uremic syndrome: differential diagnosis with the onset of inflammatory bowel diseases.
    Bianchi L, Gaiani F, Vincenzi F, Kayali S, Di Mario F, Leandro G, De' Angelis GL, Ruberto C.
    Acta Biomed; 2018 Dec 17; 89(9-S):153-157. PubMed ID: 30561409
    [Abstract] [Full Text] [Related]

  • 17. Severely ill pediatric patients with Shiga toxin-associated hemolytic uremic syndrome (STEC-HUS) who suffered from multiple organ involvement in the early stage.
    Luna M, Kamariski M, Principi I, Bocanegra V, Vallés PG.
    Pediatr Nephrol; 2021 Jun 17; 36(6):1499-1509. PubMed ID: 33205220
    [Abstract] [Full Text] [Related]

  • 18. Shiga Toxin-Producing Escherichia coli Infection, Antibiotics, and Risk of Developing Hemolytic Uremic Syndrome: A Meta-analysis.
    Freedman SB, Xie J, Neufeld MS, Hamilton WL, Hartling L, Tarr PI, Alberta Provincial Pediatric Enteric Infection Team (APPETITE), Nettel-Aguirre A, Chuck A, Lee B, Johnson D, Currie G, Talbot J, Jiang J, Dickinson J, Kellner J, MacDonald J, Svenson L, Chui L, Louie M, Lavoie M, Eltorki M, Vanderkooi O, Tellier R, Ali S, Drews S, Graham T, Pang XL.
    Clin Infect Dis; 2016 May 15; 62(10):1251-1258. PubMed ID: 26917812
    [Abstract] [Full Text] [Related]

  • 19. Virulence factors of Shiga toxin-producing Escherichia coli and the risk of developing haemolytic uraemic syndrome in Norway, 1992-2013.
    Naseer U, Løbersli I, Hindrum M, Bruvik T, Brandal LT.
    Eur J Clin Microbiol Infect Dis; 2017 Sep 15; 36(9):1613-1620. PubMed ID: 28391537
    [Abstract] [Full Text] [Related]

  • 20. Hemolytic uremic syndrome due to Shiga toxin-producing Escherichia coli infection.
    Bruyand M, Mariani-Kurkdjian P, Gouali M, de Valk H, King LA, Le Hello S, Bonacorsi S, Loirat C.
    Med Mal Infect; 2018 May 15; 48(3):167-174. PubMed ID: 29054297
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.